A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States.

ABSTRACT:

Background

Following approval of fremanezumab for the prevention of migraine in adults, health care decision makers are interested in understanding real-world clinical characteristics and treatment patterns among patients initiating fremanezumab therapy.

Methods

Data were obtained for this retrospective (pre-post) study from the Veradigm Health Insights database. The study period was January 1, 2014, to June 30, 2019. Patients were included if they were aged ≥ 18 years; had ≥ 1 migraine diagnosis during the study period; and had a medication record for fremanezumab on or after diagnosis during the identification period (September 1, 2018-December 31, 2018). Treatment patterns, including adherence, persistence, and utilization of acute and preventive migraine medication presc

SUBMITTER: Krasenbaum LJ 

PROVIDER: S-EPMC9066733 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature